![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche obesity drug helps patients](https://a.storyblok.com/f/176343/1920x1080/0234c60f2d/home-teaser.jpg)
glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche obesity drug helps patients
USD29.36
USD70.36
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche obesity drug helps patients](https://www.reuters.com/resizer/v2/SOYVZNKZ3NISLCSKGWUWF7DQGQ.jpg?auth=6d7d99c63e0f6c636c134ac90087ca30f438d260f418bd41f920ebe83b483f95&width=1200&quality=80)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche obesity drug helps patients](https://images.ctfassets.net/jj2wf7627pjc/1mKPcDT3SagTc7xVxQXE4e/20ffd9330c1518e7d8922ad2a8041cb3/ripple-effect-of-glp1s-2x.jpg)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche obesity drug helps patients](https://d3t5t78xsxj5vn.cloudfront.net/Pictures/380x253/1/8/4/20184_cdcwithdomina500_918232.jpg)
![glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche obesity drug helps patients](https://rejuven8peptides.com/wp-content/uploads/2026/02/rejuven8-peptides-glp1-5mg.png)
